The Sudan and Ebola viruses both come from the orthoebola virus family, but they have different proteins and genetic components, so the immune response to each virus is different.

In a global first, Uganda's Ministry of Health, the World Health Organization (WHO) and other partners on Feb.03 launched a first-ever clinical efficacy trial for a vaccine from Ebola from the ...

The Sudan and Ebola viruses both come from the orthoebolavirus family, but they have different proteins and genetic components, so the immune response to each virus is different.

On Jan. 30, Uganda confirmed an outbreak of the Sudan virus disease. The Sudan virus belongs to the same family as the Ebola virus. The announcement came after the death of a 32-year-old nurse in ...

The Sudan vaccine is similarly designed vaccine to Ervebo. It is said to be one of the most promising types of vaccine against Ebola and other so-called filoviruses, including Marburg.

Discovered in 1976, Ebola is rare, deadly and has multiple variants. There is a vaccine for the Zaire type. Now, trials for another strain are underway.

A new study finds that the Sudan virus, a deadly Ebola relative, binds to human NPC1 receptors with nine times greater affinity than Ebola. Using cryo-electron microscopy, researchers mapped its ...

Uganda has begun a clinical trial of a vaccine against the Sudan strain of Ebola following an outbreak that has killed one nurse in the east African country.

A new Ebola Sudan vaccine trial is underway And other major health news you need to read this morning. Lancet Infectious Diseases By Theresa Gaffney Feb. 4, 2025 Morning Rounds Writer and Podcast ...

The Sudan virus, a close relative of Ebola, has a fatality rate of 50% but remains poorly understood in terms of how it infects cells. Currently, no approved treatments exist. To address this ...